Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: A phase 3, randomized, controlled study von Mohiuddin, Syed M., MD, Pepine, Carl J., MD, Kelly, Maureen T., MD, Buttler, Susan M., BS, Setze, Carolyn M., MS, Sleep, Darryl J., MD, Stolzenbach, James C., PhD

Volltext

Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination With Atorvastatin in Patients With Mixed Dyslipidemia von Goldberg, Anne C., MD, Bays, Harold E., MD, Ballantyne, Christie M., MD, Kelly, Maureen T., MD, Buttler, Susan M., BS, Setze, Carolyn M., MS, Sleep, Darryl J., MD, Stolzenbach, James C., PhD

Volltext

A Randomized, Double-Blind Study of Fenofibric Acid Plus Rosuvastatin Compared With Rosuvastatin Alone in Stage 3 Chronic Kidney Disease von Weinstein, Debra L., MD, CPI, Williams, Laura A., MD, Carlson, Dawn M., MD, Kelly, Maureen T., MD, Burns, Kim M., BA, Setze, Carolyn M., MS, Lele, Aditya, MS, Stolzenbach, James C., PhD

Volltext

Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia von Jones, Peter H., MD, Goldberg, Anne C., MD, Knapp, Howard R., MD, PhD, Kelly, Maureen T., MD, Setze, Carolyn M., MS, Stolzenbach, James C., PhD, Sleep, Darryl J., MD

Volltext

Efficacy of Fenofibric Acid Plus Statins on Multiple Lipid Parameters and Its Safety in Women With Mixed Dyslipidemia von Goldberg, Anne C., MD, Bittner, Vera, MD, MSPH, Pepine, Carl J., MD, Kelly, Maureen T., MD, Thakker, Kamlesh, BPharm, PhD, Setze, Carolyn M., MS, Lele, Aditya, MS, Sleep, Darryl J., MD

Volltext

Effects of Fenofibric Acid on Carotid Intima-Media Thickness in Patients With Mixed Dyslipidemia on Atorvastatin Therapy: Randomized, Placebo-Controlled Study (FIRST) von Davidson, Michael H, Rosenson, Robert S, Maki, Kevin C, Nicholls, Stephen J, Ballantyne, Christie M, Mazzone, Theodore, Carlson, Dawn M, Williams, Laura A, Kelly, Maureen T, Camp, Heidi S, Lele, Aditya, Stolzenbach, James C

Volltext

Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia von Bays, Harold E., MD, Jones, Peter H., MD, Mohiuddin, Syed M., MD, Kelly, Maureen T., MD, Sun, Hsiaoming, MS, Setze, Carolyn M., MS, Buttler, Susan M., BS, Sleep, Darryl J., MD, Stolzenbach, James C., PhD

Volltext

Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: A pooled analys... von Roth, Eli M., MD, FACC, Rosenson, Robert S., MD, Jones, Peter H., MD, Davidson, Michael H., MD, FNLA, Kelly, Maureen T., MD, Setze, Carolyn M., MS, Lele, Aditya, MS, Thakker, Kamlesh, BPharm, PhD

Volltext

Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies von Jones, Peter H., MD, Davidson, Michael H., MD, Goldberg, Anne C., MD, Pepine, Carl J., MD, Kelly, Maureen T., MD, Buttler, Susan M., BS, Setze, Carolyn M., MS, Lele, Aditya, MS, Sleep, Darryl J., MD, Stolzenbach, James C., PhD

Volltext

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study von Jones, Peter H, Davidson, Michael H, Kashyap, Moti L, Kelly, Maureen T, Buttler, Susan M, Setze, Carolyn M, Sleep, Darryl J, Stolzenbach, James C

Volltext

Comparison of the Gastrointestinal Absorption and Bioavailability of Fenofibrate and Fenofibric Acid in Humans von Zhu, Tong, Ansquer, Jean-Claude, Kelly, Maureen T., Sleep, Darryl J., Pradhan, Rajendra S.

Volltext

The Effects of Fenofibric Acid Alone and With Statins on the Prevalence of Metabolic Syndrome and Its Diagnostic Components in Patients With Mixed Dyslipidemia von BAYS, Harold E, ROTH, Eli M, MCKENNEY, James M, KELLY, Maureen T, THAKKER, Kamlesh M, SETZE, Carolyn M, OBERMEYER, Katie, SLEEP, Darryl J

Volltext

BASELINE VLDL-C IS SIGNIFICANTLY ASSOCIATED WITH TRIGLYCERIDE RESPONSE TO TREATMENT WITH FENOFIBRIC ACID, STATINS, OR THEIR COMBINATION von Voros, Szilard, Rinehart, Sarah, Joshi, Parag, Thakker, Kamlesh, Lele, Aditya, Setze, Carolyn M, Kelly, Maureen T

Volltext

Long-Term Efficacy of Adding Fenofibric Acid to Moderate-Dose Statin Therapy in Patients with Persistent Elevated Triglycerides von Ballantyne, Christie M., Jones, Peter H., Kelly, Maureen T., Setze, Carolyn M., Lele, Aditya, Thakker, Kamlesh M., Stolzenbach, James C.

Volltext

ABT-335, the Choline Salt of Fenofibric Acid, Does Not Have a Clinically Significant Pharmacokinetic Interaction With Rosuvastatin in Humans von Zhu, Tong, Awni, Walid M., Hosmane, Balakrishna, Kelly, Maureen T., Sleep, Darryl J., Stolzenbach, James C., Wan, Katty, Chira, Titus O., Pradhan, Rajendra S.

Volltext

Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia: A Randomi... von Roth, Eli M., McKenney, James M., Kelly, Maureen T., Setze, Carolyn M., Carlson, Dawn M., Gold, Alex, Stolzenbach, James C., Williams, Laura A., Jones, Peter H.

Volltext

One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia: Evaluation of Dose Response von Ferdinand, Keith C., Davidson, Michael H., Kelly, Maureen T., Setze, Carolyn M.

Volltext

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus von Rosenson, Robert S., Carlson, Dawn M., Kelly, Maureen T., Setze, Carolyn M., Hirshberg, Boaz, Stolzenbach, James C., Williams, Laura A.

Volltext

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgr... von Jones, Peter H., Cusi, Kenneth, Davidson, Michael H., Kelly, Maureen T., Setze, Carolyn M., Thakker, Kamlesh, Sleep, Darryl J., Stolzenbach, C.

Volltext

Evaluation of a New Formulation of Fenofibric Acid, ABT-335,Co-Administered with Statins: Study Design and Rationale of a Phase III Clinical Programme von Jones, Peter H., Bays, Harold E., Davidson, Michael H., Kelly, Maureen T., Buttler, Susan M., Setze, Carolyn M., Sleep, Darryl J., Stolzenbach, James C.

Volltext